| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cilia | 10 | 2022 | 41 | 3.280 |
Why?
|
| TRPP Cation Channels | 18 | 2020 | 26 | 2.900 |
Why?
|
| TRPC Cation Channels | 9 | 2024 | 33 | 1.550 |
Why?
|
| Microtubule-Associated Proteins | 3 | 2021 | 49 | 1.350 |
Why?
|
| Membrane Proteins | 9 | 2014 | 466 | 1.250 |
Why?
|
| Cell Cycle | 3 | 2015 | 155 | 1.210 |
Why?
|
| Calcium Channels | 8 | 2014 | 32 | 1.130 |
Why?
|
| Polycystic Kidney, Autosomal Dominant | 11 | 2020 | 36 | 0.970 |
Why?
|
| Calcium Signaling | 7 | 2020 | 68 | 0.930 |
Why?
|
| Animals | 36 | 2024 | 9945 | 0.920 |
Why?
|
| F-Box-WD Repeat-Containing Protein 7 | 2 | 2021 | 5 | 0.910 |
Why?
|
| Cell Cycle Proteins | 2 | 2015 | 184 | 0.770 |
Why?
|
| Signal Transduction | 12 | 2021 | 1338 | 0.740 |
Why?
|
| Mice | 21 | 2024 | 4401 | 0.730 |
Why?
|
| Calcium | 7 | 2017 | 231 | 0.720 |
Why?
|
| Cell Membrane | 5 | 2016 | 235 | 0.720 |
Why?
|
| Multiprotein Complexes | 1 | 2020 | 50 | 0.670 |
Why?
|
| Wnt Signaling Pathway | 3 | 2016 | 54 | 0.630 |
Why?
|
| Ubiquitination | 2 | 2015 | 32 | 0.610 |
Why?
|
| Ion Channel Gating | 3 | 2018 | 18 | 0.580 |
Why?
|
| Ubiquitin-Protein Ligases | 2 | 2015 | 69 | 0.520 |
Why?
|
| Cyclin-Dependent Kinase 5 | 1 | 2015 | 6 | 0.510 |
Why?
|
| F-Box Proteins | 1 | 2015 | 10 | 0.510 |
Why?
|
| Proteins | 7 | 2006 | 244 | 0.500 |
Why?
|
| Proteolysis | 1 | 2015 | 55 | 0.500 |
Why?
|
| Ion Channels | 3 | 2008 | 22 | 0.500 |
Why?
|
| Kidney | 9 | 2022 | 275 | 0.480 |
Why?
|
| Miosis | 1 | 2014 | 3 | 0.470 |
Why?
|
| Myopathies, Structural, Congenital | 1 | 2014 | 3 | 0.470 |
Why?
|
| Ichthyosis | 1 | 2014 | 6 | 0.470 |
Why?
|
| Blood Platelet Disorders | 1 | 2014 | 10 | 0.460 |
Why?
|
| Myogenic Regulatory Factors | 3 | 2020 | 20 | 0.460 |
Why?
|
| Dyslexia | 1 | 2014 | 6 | 0.460 |
Why?
|
| Migraine Disorders | 1 | 2014 | 21 | 0.460 |
Why?
|
| Spleen | 1 | 2014 | 109 | 0.450 |
Why?
|
| Osteoclasts | 1 | 2013 | 28 | 0.430 |
Why?
|
| Neoplasm Proteins | 1 | 2014 | 122 | 0.430 |
Why?
|
| Protein Binding | 8 | 2020 | 631 | 0.420 |
Why?
|
| Humans | 31 | 2021 | 26797 | 0.410 |
Why?
|
| Polycystic Kidney Diseases | 3 | 2022 | 26 | 0.390 |
Why?
|
| Mutation | 8 | 2022 | 818 | 0.380 |
Why?
|
| Morphogenesis | 1 | 2011 | 21 | 0.380 |
Why?
|
| Cell Division | 3 | 2013 | 153 | 0.360 |
Why?
|
| Epidermal Growth Factor | 2 | 2005 | 23 | 0.310 |
Why?
|
| Stromal Interaction Molecule 1 | 2 | 2019 | 8 | 0.290 |
Why?
|
| Cell Line | 7 | 2013 | 672 | 0.290 |
Why?
|
| Carrier Proteins | 2 | 2009 | 244 | 0.290 |
Why?
|
| Mice, Knockout | 5 | 2024 | 781 | 0.290 |
Why?
|
| Molecular Biology | 1 | 2006 | 16 | 0.280 |
Why?
|
| NIH 3T3 Cells | 2 | 2020 | 44 | 0.270 |
Why?
|
| Cell Differentiation | 3 | 2023 | 394 | 0.260 |
Why?
|
| Megakaryocytes | 2 | 2023 | 29 | 0.250 |
Why?
|
| Models, Biological | 4 | 2021 | 446 | 0.250 |
Why?
|
| Centrosome | 2 | 2020 | 10 | 0.250 |
Why?
|
| Microtubules | 2 | 2021 | 89 | 0.240 |
Why?
|
| Transient Receptor Potential Channels | 2 | 2018 | 4 | 0.230 |
Why?
|
| Spindle Apparatus | 1 | 2004 | 52 | 0.230 |
Why?
|
| Metabolic Syndrome | 1 | 2024 | 77 | 0.220 |
Why?
|
| DNA Primers | 2 | 2014 | 143 | 0.220 |
Why?
|
| Transfection | 8 | 2008 | 312 | 0.220 |
Why?
|
| Phosphatidylinositol 4,5-Diphosphate | 2 | 2018 | 8 | 0.220 |
Why?
|
| Zebrafish | 3 | 2014 | 95 | 0.210 |
Why?
|
| Bone Marrow | 1 | 2023 | 76 | 0.210 |
Why?
|
| Membrane Potentials | 3 | 2014 | 61 | 0.210 |
Why?
|
| GTP-Binding Proteins | 4 | 2020 | 43 | 0.210 |
Why?
|
| Base Sequence | 2 | 2014 | 573 | 0.210 |
Why?
|
| Molecular Sequence Data | 8 | 2014 | 1034 | 0.210 |
Why?
|
| Tumor Suppressor Protein p53 | 2 | 2020 | 98 | 0.200 |
Why?
|
| Cysts | 1 | 2022 | 21 | 0.200 |
Why?
|
| Polymerization | 1 | 2021 | 14 | 0.200 |
Why?
|
| Male | 6 | 2024 | 12858 | 0.190 |
Why?
|
| Gene Expression Regulation | 4 | 2014 | 628 | 0.190 |
Why?
|
| RNA, Messenger | 7 | 2020 | 645 | 0.190 |
Why?
|
| Tumor Suppressor p53-Binding Protein 1 | 1 | 2020 | 6 | 0.180 |
Why?
|
| HEK293 Cells | 3 | 2017 | 171 | 0.180 |
Why?
|
| Ubiquitin Thiolesterase | 1 | 2020 | 14 | 0.180 |
Why?
|
| Actin Cytoskeleton | 1 | 2020 | 23 | 0.180 |
Why?
|
| Parathyroid Hormone | 1 | 2020 | 23 | 0.180 |
Why?
|
| Phenotype | 3 | 2024 | 664 | 0.180 |
Why?
|
| Fibronectins | 1 | 2020 | 28 | 0.170 |
Why?
|
| Cancellous Bone | 1 | 2019 | 2 | 0.170 |
Why?
|
| Gingiva | 1 | 2019 | 7 | 0.170 |
Why?
|
| Hair | 1 | 2019 | 15 | 0.170 |
Why?
|
| Xenopus | 2 | 2017 | 28 | 0.170 |
Why?
|
| Rats | 8 | 2020 | 1544 | 0.170 |
Why?
|
| Mitosis | 1 | 2020 | 109 | 0.170 |
Why?
|
| Two-Hybrid System Techniques | 5 | 2008 | 31 | 0.170 |
Why?
|
| Disease Models, Animal | 2 | 2024 | 1392 | 0.160 |
Why?
|
| Electrophysiology | 4 | 2008 | 150 | 0.160 |
Why?
|
| Female | 6 | 2024 | 14437 | 0.150 |
Why?
|
| Recombinant Proteins | 6 | 2003 | 407 | 0.150 |
Why?
|
| Patch-Clamp Techniques | 3 | 2014 | 30 | 0.150 |
Why?
|
| Sorting Nexins | 1 | 2017 | 6 | 0.150 |
Why?
|
| Structure-Activity Relationship | 2 | 2018 | 200 | 0.150 |
Why?
|
| Oxotremorine | 2 | 2008 | 2 | 0.140 |
Why?
|
| Mitochondrial Membrane Transport Proteins | 1 | 2017 | 23 | 0.140 |
Why?
|
| Calcium-Binding Proteins | 1 | 2017 | 60 | 0.140 |
Why?
|
| Endocytosis | 1 | 2017 | 81 | 0.140 |
Why?
|
| Glycolysis | 1 | 2017 | 82 | 0.140 |
Why?
|
| Cation Transport Proteins | 1 | 2017 | 54 | 0.140 |
Why?
|
| Dishevelled Proteins | 1 | 2016 | 5 | 0.140 |
Why?
|
| RNA Interference | 3 | 2007 | 135 | 0.130 |
Why?
|
| Protein Subunits | 2 | 2008 | 40 | 0.130 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2017 | 145 | 0.130 |
Why?
|
| Gene Knockdown Techniques | 1 | 2016 | 131 | 0.130 |
Why?
|
| BALB 3T3 Cells | 1 | 2015 | 5 | 0.130 |
Why?
|
| Mutagenesis, Site-Directed | 2 | 2014 | 129 | 0.130 |
Why?
|
| Protein Structure, Tertiary | 3 | 2008 | 283 | 0.130 |
Why?
|
| Mice, Inbred C57BL | 1 | 2020 | 1471 | 0.130 |
Why?
|
| Protein Conformation | 2 | 2014 | 250 | 0.130 |
Why?
|
| Fibroblasts | 1 | 2016 | 152 | 0.130 |
Why?
|
| Genes, Immediate-Early | 1 | 1995 | 5 | 0.120 |
Why?
|
| Kidney Tubules | 5 | 2017 | 21 | 0.120 |
Why?
|
| Recombinant Fusion Proteins | 4 | 2008 | 228 | 0.120 |
Why?
|
| Protein Biosynthesis | 2 | 2013 | 106 | 0.120 |
Why?
|
| ORAI1 Protein | 1 | 2014 | 6 | 0.120 |
Why?
|
| Erythrocytes, Abnormal | 1 | 2014 | 13 | 0.120 |
Why?
|
| Phosphatidylinositol 3-Kinases | 2 | 2005 | 129 | 0.120 |
Why?
|
| Pedigree | 1 | 2014 | 151 | 0.110 |
Why?
|
| Cell Membrane Permeability | 1 | 2014 | 42 | 0.110 |
Why?
|
| Codon | 1 | 2013 | 22 | 0.110 |
Why?
|
| Muscle Fatigue | 1 | 2014 | 74 | 0.110 |
Why?
|
| Sequence Analysis, DNA | 1 | 2014 | 364 | 0.100 |
Why?
|
| Endothelial Growth Factors | 3 | 1998 | 6 | 0.100 |
Why?
|
| Lymphokines | 3 | 1998 | 8 | 0.100 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2012 | 49 | 0.100 |
Why?
|
| Homeodomain Proteins | 1 | 2012 | 74 | 0.100 |
Why?
|
| Amino Acid Sequence | 6 | 2012 | 673 | 0.100 |
Why?
|
| Hedgehog Proteins | 1 | 2011 | 33 | 0.100 |
Why?
|
| Cytoplasmic Dyneins | 1 | 2011 | 3 | 0.100 |
Why?
|
| Zebrafish Proteins | 1 | 2011 | 19 | 0.090 |
Why?
|
| Ovarian Neoplasms | 1 | 2017 | 563 | 0.090 |
Why?
|
| Brain | 2 | 2002 | 698 | 0.090 |
Why?
|
| HeLa Cells | 2 | 2017 | 206 | 0.090 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2014 | 662 | 0.090 |
Why?
|
| beta Catenin | 2 | 2012 | 62 | 0.090 |
Why?
|
| Cardiomegaly | 1 | 2009 | 18 | 0.090 |
Why?
|
| Phosphotransferases (Alcohol Group Acceptor) | 2 | 2009 | 27 | 0.090 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2007 | 441 | 0.080 |
Why?
|
| Epithelial Cells | 2 | 2008 | 240 | 0.080 |
Why?
|
| LLC-PK1 Cells | 2 | 2008 | 6 | 0.080 |
Why?
|
| Mutation, Missense | 2 | 2008 | 67 | 0.080 |
Why?
|
| Stress, Physiological | 1 | 2009 | 90 | 0.080 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p57 | 1 | 2008 | 3 | 0.080 |
Why?
|
| Cyclin-Dependent Kinase 2 | 1 | 2008 | 7 | 0.080 |
Why?
|
| Myocardium | 1 | 2009 | 171 | 0.080 |
Why?
|
| Type C Phospholipases | 2 | 2005 | 31 | 0.080 |
Why?
|
| CHO Cells | 3 | 2003 | 96 | 0.080 |
Why?
|
| Cricetinae | 3 | 2003 | 129 | 0.080 |
Why?
|
| Swine | 2 | 2008 | 220 | 0.080 |
Why?
|
| Mitogen-Activated Protein Kinases | 2 | 1999 | 83 | 0.080 |
Why?
|
| rhoA GTP-Binding Protein | 1 | 2008 | 18 | 0.080 |
Why?
|
| Peptide Fragments | 4 | 2004 | 196 | 0.080 |
Why?
|
| Plasmids | 2 | 2008 | 121 | 0.070 |
Why?
|
| Child | 1 | 2014 | 2141 | 0.070 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2008 | 77 | 0.070 |
Why?
|
| Immunohistochemistry | 2 | 2008 | 453 | 0.070 |
Why?
|
| Heart Failure | 1 | 2009 | 231 | 0.070 |
Why?
|
| Protein Isoforms | 2 | 2003 | 117 | 0.070 |
Why?
|
| Muscle Development | 1 | 2005 | 7 | 0.070 |
Why?
|
| Phospholipase C gamma | 1 | 2005 | 13 | 0.060 |
Why?
|
| ErbB Receptors | 1 | 2005 | 96 | 0.060 |
Why?
|
| Transcription Factors | 2 | 2012 | 511 | 0.060 |
Why?
|
| Stem Cells | 1 | 2005 | 113 | 0.060 |
Why?
|
| Alleles | 1 | 2005 | 347 | 0.060 |
Why?
|
| Tubulin | 1 | 2004 | 30 | 0.060 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinases | 3 | 1999 | 31 | 0.060 |
Why?
|
| Glomerular Mesangium | 1 | 2003 | 5 | 0.060 |
Why?
|
| Myogenin | 1 | 2003 | 4 | 0.060 |
Why?
|
| Precipitin Tests | 1 | 2003 | 47 | 0.060 |
Why?
|
| Cytoplasm | 1 | 2003 | 57 | 0.060 |
Why?
|
| Dimerization | 2 | 2008 | 75 | 0.060 |
Why?
|
| Cysteine | 1 | 2003 | 67 | 0.050 |
Why?
|
| Hematopoiesis | 1 | 2023 | 24 | 0.050 |
Why?
|
| Receptor, Insulin | 1 | 2004 | 93 | 0.050 |
Why?
|
| Cell Lineage | 1 | 2023 | 44 | 0.050 |
Why?
|
| Blood Pressure | 1 | 2024 | 351 | 0.050 |
Why?
|
| Bone Marrow Cells | 1 | 2023 | 79 | 0.050 |
Why?
|
| Mice, Inbred BALB C | 1 | 2003 | 263 | 0.050 |
Why?
|
| Cell Line, Tumor | 3 | 2017 | 1263 | 0.050 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2020 | 545 | 0.050 |
Why?
|
| Muscle, Smooth | 1 | 2002 | 40 | 0.050 |
Why?
|
| Sequence Homology, Amino Acid | 2 | 1999 | 130 | 0.050 |
Why?
|
| Sequence Alignment | 2 | 1999 | 110 | 0.050 |
Why?
|
| Antibodies, Monoclonal | 1 | 2003 | 316 | 0.050 |
Why?
|
| Transcription Factor AP-1 | 2 | 1999 | 26 | 0.050 |
Why?
|
| Protein Kinase C | 2 | 1999 | 72 | 0.050 |
Why?
|
| Binding Sites | 2 | 1999 | 338 | 0.050 |
Why?
|
| Apoptosis | 2 | 2017 | 739 | 0.050 |
Why?
|
| Heparan Sulfate Proteoglycans | 1 | 2001 | 9 | 0.050 |
Why?
|
| Liver | 1 | 2003 | 415 | 0.050 |
Why?
|
| Retina | 1 | 2004 | 413 | 0.050 |
Why?
|
| Parathyroid Glands | 1 | 2020 | 6 | 0.040 |
Why?
|
| Hypercalcemia | 1 | 2020 | 12 | 0.040 |
Why?
|
| Collagen | 1 | 2001 | 147 | 0.040 |
Why?
|
| Mesangial Cells | 1 | 2020 | 9 | 0.040 |
Why?
|
| Kidney Glomerulus | 1 | 2020 | 15 | 0.040 |
Why?
|
| Osteocytes | 1 | 2019 | 2 | 0.040 |
Why?
|
| Cortical Bone | 1 | 2019 | 2 | 0.040 |
Why?
|
| Splenomegaly | 1 | 2019 | 10 | 0.040 |
Why?
|
| Incisor | 1 | 2019 | 7 | 0.040 |
Why?
|
| Ribs | 1 | 2019 | 3 | 0.040 |
Why?
|
| Homozygote | 1 | 2019 | 36 | 0.040 |
Why?
|
| Thorax | 1 | 2019 | 28 | 0.040 |
Why?
|
| Kyphosis | 1 | 2019 | 19 | 0.040 |
Why?
|
| X-Ray Microtomography | 1 | 2019 | 31 | 0.040 |
Why?
|
| Osteoblasts | 1 | 2019 | 35 | 0.040 |
Why?
|
| RGS Proteins | 1 | 1999 | 5 | 0.040 |
Why?
|
| Bone and Bones | 1 | 2019 | 74 | 0.040 |
Why?
|
| Diet, High-Fat | 1 | 2020 | 130 | 0.040 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 2020 | 96 | 0.040 |
Why?
|
| Blood Glucose | 1 | 2020 | 300 | 0.040 |
Why?
|
| Reactive Oxygen Species | 1 | 2020 | 278 | 0.040 |
Why?
|
| Phosphorylation | 4 | 2004 | 558 | 0.040 |
Why?
|
| Isoenzymes | 1 | 1998 | 86 | 0.040 |
Why?
|
| Xenopus laevis | 1 | 2018 | 47 | 0.040 |
Why?
|
| Protein Domains | 1 | 2018 | 48 | 0.040 |
Why?
|
| Antioxidants | 1 | 2020 | 221 | 0.040 |
Why?
|
| Neovascularization, Pathologic | 2 | 1995 | 144 | 0.040 |
Why?
|
| Gene Expression | 2 | 2001 | 406 | 0.040 |
Why?
|
| Tumor Cells, Cultured | 4 | 2002 | 310 | 0.040 |
Why?
|
| Pyruvate Dehydrogenase Complex | 1 | 2017 | 19 | 0.040 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 1998 | 95 | 0.040 |
Why?
|
| Oxidative Phosphorylation | 1 | 2017 | 26 | 0.040 |
Why?
|
| Vesicular Transport Proteins | 1 | 2017 | 30 | 0.040 |
Why?
|
| Microarray Analysis | 1 | 2017 | 59 | 0.040 |
Why?
|
| Proteasome Endopeptidase Complex | 2 | 2012 | 80 | 0.040 |
Why?
|
| Cisplatin | 1 | 2017 | 172 | 0.030 |
Why?
|
| Mice, Nude | 1 | 2017 | 313 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-akt | 2 | 2009 | 146 | 0.030 |
Why?
|
| Oncogene Protein pp60(v-src) | 1 | 1995 | 6 | 0.030 |
Why?
|
| Genes, src | 1 | 1995 | 4 | 0.030 |
Why?
|
| Genes, p53 | 1 | 1995 | 14 | 0.030 |
Why?
|
| Proto-Oncogene Proteins pp60(c-src) | 1 | 1995 | 7 | 0.030 |
Why?
|
| RNA, Small Interfering | 2 | 2007 | 194 | 0.030 |
Why?
|
| Hydrolysis | 1 | 1995 | 58 | 0.030 |
Why?
|
| Mice, Mutant Strains | 1 | 1995 | 58 | 0.030 |
Why?
|
| Promoter Regions, Genetic | 1 | 1995 | 333 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 1995 | 587 | 0.030 |
Why?
|
| Cells, Cultured | 2 | 2008 | 968 | 0.030 |
Why?
|
| Half-Life | 1 | 2012 | 32 | 0.030 |
Why?
|
| von Hippel-Lindau Disease | 1 | 2012 | 9 | 0.030 |
Why?
|
| Von Hippel-Lindau Tumor Suppressor Protein | 1 | 2012 | 11 | 0.030 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2012 | 29 | 0.030 |
Why?
|
| Vascular Endothelial Growth Factors | 3 | 1998 | 6 | 0.030 |
Why?
|
| Up-Regulation | 1 | 2012 | 240 | 0.020 |
Why?
|
| Antineoplastic Agents | 1 | 2017 | 656 | 0.020 |
Why?
|
| Vascular Endothelial Growth Factor A | 3 | 1998 | 175 | 0.020 |
Why?
|
| Nuclear Proteins | 1 | 2012 | 245 | 0.020 |
Why?
|
| Tyrosine | 2 | 2004 | 90 | 0.020 |
Why?
|
| Calcineurin | 1 | 2009 | 7 | 0.020 |
Why?
|
| Mechanotransduction, Cellular | 1 | 2009 | 23 | 0.020 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2009 | 68 | 0.020 |
Why?
|
| Transcription, Genetic | 2 | 2002 | 399 | 0.020 |
Why?
|
| p21-Activated Kinases | 1 | 2008 | 6 | 0.020 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 2 | 1999 | 33 | 0.020 |
Why?
|
| 3T3 Cells | 2 | 2001 | 44 | 0.020 |
Why?
|
| Animals, Genetically Modified | 1 | 2008 | 52 | 0.020 |
Why?
|
| STAT1 Transcription Factor | 1 | 2008 | 37 | 0.020 |
Why?
|
| Point Mutation | 1 | 2008 | 60 | 0.020 |
Why?
|
| Amino Acid Substitution | 1 | 2008 | 102 | 0.020 |
Why?
|
| Lanthanoid Series Elements | 1 | 2008 | 2 | 0.020 |
Why?
|
| Amiloride | 1 | 2008 | 3 | 0.020 |
Why?
|
| Muscarinic Agonists | 1 | 2008 | 9 | 0.020 |
Why?
|
| Sodium Channel Blockers | 1 | 2008 | 11 | 0.020 |
Why?
|
| Inositol 1,4,5-Trisphosphate Receptors | 1 | 2007 | 5 | 0.020 |
Why?
|
| Cytosol | 1 | 2007 | 47 | 0.020 |
Why?
|
| Neurons | 1 | 2008 | 275 | 0.020 |
Why?
|
| Cell Fractionation | 1 | 2005 | 18 | 0.020 |
Why?
|
| Immunoprecipitation | 1 | 2005 | 67 | 0.020 |
Why?
|
| Microscopy, Fluorescence | 1 | 2005 | 161 | 0.020 |
Why?
|
| Insulin Receptor Substrate Proteins | 1 | 2004 | 22 | 0.010 |
Why?
|
| Organ Culture Techniques | 1 | 2004 | 55 | 0.010 |
Why?
|
| 3T3-L1 Cells | 1 | 2004 | 27 | 0.010 |
Why?
|
| Protein Interaction Mapping | 1 | 2004 | 34 | 0.010 |
Why?
|
| Inositol 1,4,5-Trisphosphate | 1 | 2003 | 4 | 0.010 |
Why?
|
| Thapsigargin | 1 | 2003 | 8 | 0.010 |
Why?
|
| Phosphoproteins | 1 | 2004 | 115 | 0.010 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2004 | 139 | 0.010 |
Why?
|
| Kinetics | 1 | 2003 | 538 | 0.010 |
Why?
|
| Respiratory System | 1 | 2002 | 13 | 0.010 |
Why?
|
| Insulin | 1 | 2004 | 310 | 0.010 |
Why?
|
| Liver Neoplasms, Experimental | 1 | 2002 | 27 | 0.010 |
Why?
|
| DNA, Complementary | 1 | 2002 | 76 | 0.010 |
Why?
|
| Guinea Pigs | 1 | 2002 | 73 | 0.010 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2004 | 276 | 0.010 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2002 | 323 | 0.010 |
Why?
|
| Collagen Type XVIII | 1 | 2001 | 1 | 0.010 |
Why?
|
| Endostatins | 1 | 2001 | 3 | 0.010 |
Why?
|
| Endothelium | 1 | 2001 | 28 | 0.010 |
Why?
|
| Cations | 1 | 2000 | 11 | 0.010 |
Why?
|
| Oligosaccharides | 1 | 2001 | 33 | 0.010 |
Why?
|
| Cloning, Molecular | 1 | 2001 | 204 | 0.010 |
Why?
|
| Heparin | 1 | 2001 | 110 | 0.010 |
Why?
|
| Sulfates | 1 | 2001 | 86 | 0.010 |
Why?
|
| Blotting, Western | 1 | 2002 | 503 | 0.010 |
Why?
|
| Ubiquitins | 1 | 1999 | 7 | 0.010 |
Why?
|
| Cysteine Endopeptidases | 1 | 1999 | 17 | 0.010 |
Why?
|
| Egtazic Acid | 1 | 1999 | 10 | 0.010 |
Why?
|
| Staurosporine | 1 | 1999 | 10 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-jun | 1 | 1999 | 12 | 0.010 |
Why?
|
| Multienzyme Complexes | 1 | 1999 | 29 | 0.010 |
Why?
|
| Gene Library | 1 | 1999 | 45 | 0.010 |
Why?
|
| Protein Kinase C-alpha | 1 | 1998 | 9 | 0.010 |
Why?
|
| Cell Count | 1 | 1998 | 84 | 0.010 |
Why?
|
| Enzyme Activation | 1 | 1998 | 262 | 0.010 |
Why?
|
| Saccharomyces cerevisiae | 1 | 1999 | 172 | 0.010 |
Why?
|
| B-Lymphocytes | 1 | 1999 | 275 | 0.010 |
Why?
|
| Oxygen | 1 | 1998 | 217 | 0.010 |
Why?
|
| Isoflavones | 1 | 1995 | 8 | 0.010 |
Why?
|
| Genistein | 1 | 1995 | 9 | 0.010 |
Why?
|
| DNA-Binding Proteins | 1 | 1999 | 482 | 0.010 |
Why?
|
| Cell Hypoxia | 1 | 1995 | 35 | 0.010 |
Why?
|